Hamilton James C

SEC CIK
0001830755

Latest role at each company

Trades

Every Form 4 that lists Hamilton James C as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
ARWRARROWHEAD PHARMACEUTICALS, INC.Apr 24, 2026Apr 23, 2026Hamilton James CChief Medical OfficerSSaleCommon Stock−10K$75.00−$750K226.96K−4.2%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Mar 9, 2026Mar 5, 2026Hamilton James CChief Medical OfficerSSaleCommon Stock−10K$64.19−$641.9K236.96K−4.0%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 5, 2026Jan 5, 2026Hamilton James CChief Medical OfficerSSaleCommon Stock−40.16K$63.1078−$2.53M171.96K−18.9%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Oct 3, 2025Oct 1, 2025Hamilton James CChief Medical OfficerSSaleCommon Stock−20K$35.00−$700K212.12K−8.6%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Sep 16, 2025Sep 12, 2025Hamilton James CChief Medical OfficerSSaleCommon Stock−15K$30.00−$450K232.12K−6.1%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Sep 4, 2025Sep 2, 2025Hamilton James CChief Medical OfficerSSaleCommon Stock−15K$25.00−$375K247.12K−5.7%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Aug 15, 2025Aug 13 – Aug 15, 2025Hamilton James CChief Medical OfficerSSaleCommon Stock−10K$20.00−$200K262.12K−3.7%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 7, 2025Jan 6, 2025Hamilton James CChief Discovery/Trans MedicineSSaleCommon Stock−32.73K$19.8241−$648.82K272.12K−10.7%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Apr 3, 2024Apr 1, 2024Hamilton James CChief Discovery/Trans MedicineSSaleCommon Stock−6K$28.03−$168.18K204.85K−2.8%SEC
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 17, 2024Jan 12, 2024Hamilton James CChief Discovery/Trans MedicineSSaleCommon Stock−7.94K$36.8896−$292.9K210.85K−3.6%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 5, 2024Jan 3 – Jan 5, 2024Hamilton James COther: Chief Discovery/Trans MedicineSSaleCommon Stock−38.44K$34.6885−$1.33M218.79K−14.9%SEC10b5-1
ARWRARROWHEAD PHARMACEUTICALS, INC.Jul 5, 2023Jun 30, 2023Hamilton James COther: Chief Discovery/Trans MedicineSSaleCommon Stock−3K$35.53−$106.59K188.48K−1.6%SEC
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 6, 2023Jan 5, 2023Hamilton James COther: Chief Discovery/Trans MedicineSSaleCommon Stock−13.8K$37.40−$516.23K191.48K−6.7%SEC
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 5, 2023Jan 3, 2023Hamilton James COther: Chief Discovery/Trans MedicineSSaleCommon Stock−10.34K$38.3767−$396.74K145.29K−6.6%SEC
ARWRARROWHEAD PHARMACEUTICALS, INC.Jan 6, 2022Jan 4 – Jan 5, 2022Hamilton James COther: Senior Vice PresidentSSaleCommon Stock−25.63K$64.5694−$1.65M155.63K−14.1%SEC